The Stock Exchange of Thailand The operating performance for three-month period end 30 September 2019 of Mahachai Hospital Public Company Limited compared to the prior year was increasing in net profit
Subsidiaries Financial Statement as of March 31, 2018. MDX Public Company Limited (“MDX”) would like to explain major factors that affect Q1/2018 consolidated operating results as follows: ▪ An increasing cost
MB or 108.92% due to increasing revenues from sales, services and construction. 2. The company consolidated net loss for this period -6.83 MB compare with the same period for the previous year -5.11 MB
allocated by way of Private Placement 14/06/2022 17:14 The Resolutions of Board of Directors Meeting No. 4/2022 regarding the investment in SGMP Co.,Ltd., increasing registered capital, the allocation of
or 22.94% from the same period of last year. This is result increasing in sale quantity around 20% from the same period of last year. 3. Gross profit margin was 2.61% of Revenue from sale and service
62.08 million. Compared to the same period of 2018, the loss was Baht 131.73 million, increasing of 52.87%. The Company would like to clarify significant changes in the Group’s operating results as
June 2017, the net profit was Baht 46.72 million, increased by 9.62 million or increasing by 25.9 percents in which performance for the company and its subsidiaries in the current three-month period
increasing distribution nergy throug sale perform uarter of 2017 collection an percent. Whi 853.4 million subsidiaries the subsidi financial insti 016 Ch MB 4.2 67.6 7.2 33.4 3.8 448.3 9.1 39.7 4.7 13.4 6.4
December compared to last year and we see this continuing into the first quarter of 2018. The year as a whole was focused on increasing topline growth which has been achieved with a 115mTHB or +14% increase
previous year. The profitability of methyl ester was pressured by stiffen competition with increasing supply in Thailand. Additionally, the declining of palm oil price and the falling global glycerine price